These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 29910690

  • 21. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
    Strömberg T, Feng X, Delforoush M, Berglund M, Lin Y, Axelson M, Larsson O, Georgii-Hemming P, Lennartsson J, Enblad G.
    Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
    [Abstract] [Full Text] [Related]

  • 22. The insulin-like growth factor system in advanced breast cancer.
    Helle SI.
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):67-79. PubMed ID: 14687598
    [Abstract] [Full Text] [Related]

  • 23. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.
    Westley BR, Clayton SJ, Daws MR, Molloy CA, May FE.
    Biochem Soc Symp; 1998 Mar; 63():35-44. PubMed ID: 9513709
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells.
    Richardson AE, Hamilton N, Davis W, Brito C, De León D.
    Growth Factors; 2011 Apr; 29(2-3):82-93. PubMed ID: 21410323
    [Abstract] [Full Text] [Related]

  • 27. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
    Sacco A, Morcavallo A, Pandini G, Vigneri R, Belfiore A.
    Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G, Crean SJ, Naik P, Kapas S.
    Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
    [Abstract] [Full Text] [Related]

  • 32. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
    Evdokimova V, Tognon CE, Benatar T, Yang W, Krutikov K, Pollak M, Sorensen PH, Seth A.
    Sci Signal; 2012 Dec 18; 5(255):ra92. PubMed ID: 23250396
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V, Malaguarnera R, Nicolosi ML, Palladino C, Spoleti C, Massimino M, Vigneri P, Purrello M, Ragusa M, Morrione A, Belfiore A.
    Oncotarget; 2017 Jun 27; 8(26):43248-43270. PubMed ID: 28591735
    [Abstract] [Full Text] [Related]

  • 35. Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.
    Amin O, Beauchamp MC, Nader PA, Laskov I, Iqbal S, Philip CA, Yasmeen A, Gotlieb WH.
    BMC Cancer; 2015 Oct 29; 15():817. PubMed ID: 26510816
    [Abstract] [Full Text] [Related]

  • 36. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul 29; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 37. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.
    De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG.
    Biochem Biophys Res Commun; 1988 Apr 15; 152(1):398-405. PubMed ID: 2451917
    [Abstract] [Full Text] [Related]

  • 38. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
    Varewijck AJ, Brugts MP, Frystyk J, Goudzwaard JA, Uitterlinden P, Waaijers AM, Feng Y, Dimitrov DS, Lamberts SW, Hofland LJ, Janssen JA.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):17-24. PubMed ID: 22982059
    [Abstract] [Full Text] [Related]

  • 39. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI.
    Endocrinology; 2005 Nov 05; 146(11):4609-18. PubMed ID: 16037379
    [Abstract] [Full Text] [Related]

  • 40. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B.
    J Cell Biochem; 2007 Sep 01; 102(1):28-40. PubMed ID: 17372931
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.